COAG

Conviction 57HealthcareScan · Mon, Aug 10, 2026

COAG$49.72+0.12%

ResistanceSupportVol 14Insider buy

Vol MA14 467.49K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Hemab Therapeutics Holdings, Inc.Biotechnologywww.hemab.com ↗

Price49.72

Change+0.12%

Gap+2.40%

Rel volume0.34×

Avg volume441.76K

Avg $ vol20.9M

SMA 2047.55

SMA 5036.88

SMA 200—

Price vs 50+34.81%

Price vs 200—

MA stack—

50/200 cross—

Supertrendup · 38.79

RSI (14)61

MACD hist-0.28

MACD crossbear · 8d

Stoch %K / %D66 / 73

ADX (14)32

+DI / −DI22 / 12

RSI divergenceBearish

MACD divergenceBearish

ATR %+8.24%

ADR %9.33%

52w high52.16

52w low24.98

From 52w high-4.68%

Above 52w low+99.04%

New 52w highNo

SqueezeOff

Bollinger width20.45%

%B0.72

Donchian pos74.49%

Donchian high53.61

Donchian low38.36

AVWAP (52w high)50.92

vs AVWAP high-2.36%

AVWAP (52w low)37.33

vs AVWAP low+33.19%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d0.34×

Avg vol (14d)467.49K

Avg vol (20d)441.76K

Avg $ vol (20d)20.9M

Market cap2.32B

RS 3m (vs SPY)+87.23%

RS 6m (vs SPY)—

RS line new highNo

Trend template—

Technical rank84.1

1 week+10.49%

1 month+30.74%

3 months+97.93%

6 months—

1 year—

YTD+46.24%

P/E—

P/B-11.69

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current12.85

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target50.00

Target upside0.56%

Analyst ratingBuy

Institutional0.84%

Ent. value2.27B

Revenue—

Net income-22.69M

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out46.71M

Employees—

ListedFri, May 1, 2026

Free float15.97M

Float %40.7%

Short interest1.66M

Days to cover5.3d

Short volume82.1%

Squeeze score66 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$23.98

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank84.1 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance52.88

Support25.64

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COAG

All disclosures →

No recent disclosed trades by Congress in COAG. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COAG · 7 buys

Insider	Side	Shares	Value	Traded	Filed
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Kolchinsky Peter 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-20	Buy	996	$25K	2026-05-20	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA Capital Healthcare Fund LP 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Buy	3.8K	$95K	2026-05-19	2026-05-21
RA CAPITAL MANAGEMENT, L.P. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21
Shah Rajeev M. 10% owner · Common Stock · 2026-05-19	Other	—	—	2026-05-19	2026-05-21

SEC filings

EDGAR filings in COAG · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.